Veterinary Artificial Insemination Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Animal Type (Cattle, Swine, Ovine & Caprine, Equine, Others), By Product Type (Normal Semen v/s Sexed Semen), By End User (Veterinary Hospitals & Clinics, Animal Breeding Centers, Others), By Company, and By Region
![](/report_cover/2465/veterinary-artificial-insemination-market-global-industry-size-share-trends-opportunity-n-forecast-2017-2027-segmented-by-animal-type-cattle_en.gif)
The global veterinary artificial insemination market is projected to observe an impressive growth during the forecast period, 2023-2027. The major factors include increasing demand for livestock multiplication and rising involvement of government and market players, which are propelling the growth of the market. A veterinary artificial insemination (AI) is a technique of breeding cattle that involves the use of frozen straws of sperm. It improves the genetics and reproduction of farm animals, and it is one of the most effective biotechnology techniques which is accessible to cattle producers. The other factors supporting the market's growth are increasing prevalence of contagious diseases among animals, surge in population across the globe, urbanization, advancement in techniques, and growing awareness. Additionally, rising pet industry expenditure is driving the growth of the market in upcoming years. In 2021, pet industry expenditure in the United States was USD123.6 billion.
Rising Demand for Livestock Multiplication for Increased Yield Boosts Prospects
Artificial insemination is an effective treatment than natural mating method, as it enhances the long-term profitability of cattle operations. This procedure allows more females to be fertile at different locations and be pregnant at the same time, sperms can be readily transported, and some other advantages such as increased efficiency of bull usage, and genetic selection, which are driving the growth of the veterinary artificial insemination market. Moreover, the semen produced by superior herd in single ejaculation is kept, diluted, and used to inseminate multiple females pregnant. These females produce more milk than normal offspring. Most producers gather the semen of genetically superior breed of animals and makes it available to manufacturers. This method allows farmers to select traits whatever they wish into their livestock, and also to produce progenies. For example, in 2020, Cogent in partnership with AB Europe launched a novel sexed semen service for sheep producers in the U.K. Furthermore, the AI method reduces the risks involved with animal breeding and disease transfer, which is bolstering the growth of the market.
Rising Involvement of Government and Market Players
Favorable government regulations from numerous nations are intended to enhance the productivity and profitability, rise in public knowledge, and the privatization of animal healthcare, are driving the market growth. Government organizations along with public organizations have given mutual economic resources for artificial insemination techniques, to prevent and control infectious diseases in livestock animals. For instance, in 2018, the Indian government authorized an Agriculture Export Policy to enhance agricultural economic growth in the country. The new policy is aimed at enhancing India's agricultural output to USD 60.0 billion by 2022 and USD 100.0 billion with a predictable foreign policy framework in the foreseen years. Also, the market players are implementing various strategies to support the growth of market such as joint ventures, mergers and acquisitions, product innovations and collaborations. For instance, in 2021, Elanco Animal Health established collaboration with Ducks Unlimited to encourage sustainable development and agriculture - particularly beef cattle development across North America.
Market Segmentation
The global veterinary artificial insemination market is segmented into animal type, product type, end user and company. Based on animal type, the market is segmented into cattle, swine, ovine & caprine, equine, and others. Based on product type, the market is divided into normal semen and sexed semen. Based on end user, the market is segmented into veterinary hospitals & clinics, animal breeding centers, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to rising demand for livestock in the country.
Genus ABS, URUS Group LP, CRV, SEMEX, VikingGenetics FmbA, Select Sires Inc., Swine Genetics International Ltd., Stallion AI Services Ltd, ST Genetics Germany GmbH, and Shipley Swine Genetics are some of the leading companies operating in the market.
Report Scope:
In this report, global veterinary artificial insemination market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in Veterinary Artificial Insemination Market
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
Rising Demand for Livestock Multiplication for Increased Yield Boosts Prospects
Artificial insemination is an effective treatment than natural mating method, as it enhances the long-term profitability of cattle operations. This procedure allows more females to be fertile at different locations and be pregnant at the same time, sperms can be readily transported, and some other advantages such as increased efficiency of bull usage, and genetic selection, which are driving the growth of the veterinary artificial insemination market. Moreover, the semen produced by superior herd in single ejaculation is kept, diluted, and used to inseminate multiple females pregnant. These females produce more milk than normal offspring. Most producers gather the semen of genetically superior breed of animals and makes it available to manufacturers. This method allows farmers to select traits whatever they wish into their livestock, and also to produce progenies. For example, in 2020, Cogent in partnership with AB Europe launched a novel sexed semen service for sheep producers in the U.K. Furthermore, the AI method reduces the risks involved with animal breeding and disease transfer, which is bolstering the growth of the market.
Rising Involvement of Government and Market Players
Favorable government regulations from numerous nations are intended to enhance the productivity and profitability, rise in public knowledge, and the privatization of animal healthcare, are driving the market growth. Government organizations along with public organizations have given mutual economic resources for artificial insemination techniques, to prevent and control infectious diseases in livestock animals. For instance, in 2018, the Indian government authorized an Agriculture Export Policy to enhance agricultural economic growth in the country. The new policy is aimed at enhancing India's agricultural output to USD 60.0 billion by 2022 and USD 100.0 billion with a predictable foreign policy framework in the foreseen years. Also, the market players are implementing various strategies to support the growth of market such as joint ventures, mergers and acquisitions, product innovations and collaborations. For instance, in 2021, Elanco Animal Health established collaboration with Ducks Unlimited to encourage sustainable development and agriculture - particularly beef cattle development across North America.
Market Segmentation
The global veterinary artificial insemination market is segmented into animal type, product type, end user and company. Based on animal type, the market is segmented into cattle, swine, ovine & caprine, equine, and others. Based on product type, the market is divided into normal semen and sexed semen. Based on end user, the market is segmented into veterinary hospitals & clinics, animal breeding centers, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to rising demand for livestock in the country.
Genus ABS, URUS Group LP, CRV, SEMEX, VikingGenetics FmbA, Select Sires Inc., Swine Genetics International Ltd., Stallion AI Services Ltd, ST Genetics Germany GmbH, and Shipley Swine Genetics are some of the leading companies operating in the market.
Report Scope:
In this report, global veterinary artificial insemination market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
- Veterinary Artificial Insemination Market, By Animal Type:
- Cattle
- Swine
- Ovine & Caprine
- Equine
- Others
- Veterinary Artificial Insemination Market, By Product Type:
- Normal Semen
- Sexed Semen
- Veterinary Artificial Insemination Market, By End User:
- Veterinary Hospitals & Clinics
- Animal Breeding Centers
- Others
- Veterinary Artificial Insemination Market, By Region:
- North America
- United States
- Canada
- Mexico
- Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
- Europe & CIS
- Germany
- France
- United Kingdom
- Spain
- Italy
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Company Profiles: Detailed analysis of the major companies present in Veterinary Artificial Insemination Market
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. PRODUCT OVERVIEW
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. IMPACT OF COVID-19 ON GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET
5. VOICE OF CUSTOMER
6. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Animal Type (Cattle, Swine, Ovine & Caprine, Equine, Others)
6.2.2. By Product Type (Normal Semen v/s Sexed Semen)
6.2.3. By End User (Veterinary Hospitals & Clinics, Animal Breeding Centers, Others)
6.2.4. By Company (2021)
6.2.5. By Region
6.3. Product Market Map
7. NORTH AMERICA VETERINARY ARTIFICIAL INSEMINATION MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Animal Type
7.2.2. By Product Type
7.2.3. By End User
7.2.4. By Country
7.3. North America: Country Analysis
7.3.1. United States Veterinary Artificial Insemination Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Animal Type
7.3.1.2.2. By Product Type
7.3.1.2.3. By End User
7.3.2. Mexico Veterinary Artificial Insemination Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Animal Type
7.3.2.2.2. By Product Type
7.3.2.2.3. By End User
7.3.3. Canada Veterinary Artificial Insemination Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Animal Type
7.3.3.2.2. By Product Type
7.3.3.2.3. By End User
8. EUROPE VETERINARY ARTIFICIAL INSEMINATION MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Animal Type
8.2.2. By Product Type
8.2.3. By End User
8.2.4. By Country
8.3. Europe: Country Analysis
8.3.1. France Veterinary Artificial Insemination Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Animal Type
8.3.1.2.2. By Product Type
8.3.1.2.3. By End User
8.3.2. Germany Veterinary Artificial Insemination Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Animal Type
8.3.2.2.2. By Product Type
8.3.2.2.3. By End User
8.3.3. United Kingdom Veterinary Artificial Insemination Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Animal Type
8.3.3.2.2. By Product Type
8.3.3.2.3. By End User
8.3.4. Italy Veterinary Artificial Insemination Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Animal Type
8.3.4.2.2. By Product Type
8.3.4.2.3. By End User
8.3.5. Spain Veterinary Artificial Insemination Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Animal Type
8.3.5.2.2. By Product Type
8.3.5.2.3. By End User
9. ASIA-PACIFIC VETERINARY ARTIFICIAL INSEMINATION MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Animal Type
9.2.2. By Product Type
9.2.3. By End User
9.2.4. By Country
9.3. Asia-Pacific: Country Analysis
9.3.1. China Veterinary Artificial Insemination Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Animal Type
9.3.1.2.2. By Product Type
9.3.1.2.3. By End User
9.3.2. India Veterinary Artificial Insemination Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Animal Type
9.3.2.2.2. By Product Type
9.3.2.2.3. By End User
9.3.3. South Korea Veterinary Artificial Insemination Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Animal Type
9.3.3.2.2. By Product Type
9.3.3.2.3. By End User
9.3.4. Japan Veterinary Artificial Insemination Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Animal Type
9.3.4.2.2. By Product Type
9.3.4.2.3. By End User
9.3.5. Australia Veterinary Artificial Insemination Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Animal Type
9.3.5.2.2. By Product Type
9.3.5.2.3. By End User
10. SOUTH AMERICA VETERINARY ARTIFICIAL INSEMINATION MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Animal Type
10.2.2. By Product Type
10.2.3. By End User
10.2.4. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Veterinary Artificial Insemination Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Animal Type
10.3.1.2.2. By Product Type
10.3.1.2.3. By End User
10.3.2. Argentina Veterinary Artificial Insemination Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Animal Type
10.3.2.2.2. By Product Type
10.3.2.2.3. By End User
10.3.3. Colombia Veterinary Artificial Insemination Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Animal Type
10.3.3.2.2. By Product Type
10.3.3.2.3. By End User
11. MIDDLE EAST AND AFRICA VETERINARY ARTIFICIAL INSEMINATION MARKET OUTLOOK
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Animal Type
11.2.2. By Product Type
11.2.3. By End User
11.2.4. By Country
11.3. MEA: Country Analysis
11.3.1. South Africa Veterinary Artificial Insemination Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Animal Type
11.3.1.2.2. By Product Type
11.3.1.2.3. By End User
11.3.2. Saudi Arabia Veterinary Artificial Insemination Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Animal Type
11.3.2.2.2. By Product Type
11.3.2.2.3. By End User
11.3.3. UAE Veterinary Artificial Insemination Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Animal Type
11.3.3.2.2. By Product Type
11.3.3.2.3. By End User
11.3.4. Egypt Veterinary Artificial Insemination Market Outlook
11.3.4.1. Market Size & Forecast
11.3.4.1.1. By Value
11.3.4.2. Market Share & Forecast
11.3.4.2.1. By Animal Type
11.3.4.2.2. By Product Type
11.3.4.2.3. By End User
11.3.5. Turkey Veterinary Artificial Insemination Market Outlook
11.3.5.1. Market Size & Forecast
11.3.5.1.1. By Value
11.3.5.2. Market Share & Forecast
11.3.5.2.1. By Animal Type
11.3.5.2.2. By Product Type
11.3.5.2.3. By End User
12. MARKET DYNAMICS
12.1. Drivers
12.2. Challenges
13. MARKET TRENDS & DEVELOPMENTS
14. COMPETITIVE LANDSCAPE
14.1. Genus ABS
14.2. URUS Group LP
14.3. CRV
14.4. SEMEX
14.5. VikingGenetics FmbA
14.6. Select Sires Inc.
14.7. Swine Genetics International Ltd.
14.8. Stallion AI Services Ltd
14.9. ST Genetics Germany GmbH
14.10. Shipley Swine Genetics
15. STRATEGIC RECOMMENDATIONS
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. IMPACT OF COVID-19 ON GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET
5. VOICE OF CUSTOMER
6. GLOBAL VETERINARY ARTIFICIAL INSEMINATION MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Animal Type (Cattle, Swine, Ovine & Caprine, Equine, Others)
6.2.2. By Product Type (Normal Semen v/s Sexed Semen)
6.2.3. By End User (Veterinary Hospitals & Clinics, Animal Breeding Centers, Others)
6.2.4. By Company (2021)
6.2.5. By Region
6.3. Product Market Map
7. NORTH AMERICA VETERINARY ARTIFICIAL INSEMINATION MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Animal Type
7.2.2. By Product Type
7.2.3. By End User
7.2.4. By Country
7.3. North America: Country Analysis
7.3.1. United States Veterinary Artificial Insemination Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Animal Type
7.3.1.2.2. By Product Type
7.3.1.2.3. By End User
7.3.2. Mexico Veterinary Artificial Insemination Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Animal Type
7.3.2.2.2. By Product Type
7.3.2.2.3. By End User
7.3.3. Canada Veterinary Artificial Insemination Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Animal Type
7.3.3.2.2. By Product Type
7.3.3.2.3. By End User
8. EUROPE VETERINARY ARTIFICIAL INSEMINATION MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Animal Type
8.2.2. By Product Type
8.2.3. By End User
8.2.4. By Country
8.3. Europe: Country Analysis
8.3.1. France Veterinary Artificial Insemination Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Animal Type
8.3.1.2.2. By Product Type
8.3.1.2.3. By End User
8.3.2. Germany Veterinary Artificial Insemination Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Animal Type
8.3.2.2.2. By Product Type
8.3.2.2.3. By End User
8.3.3. United Kingdom Veterinary Artificial Insemination Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Animal Type
8.3.3.2.2. By Product Type
8.3.3.2.3. By End User
8.3.4. Italy Veterinary Artificial Insemination Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Animal Type
8.3.4.2.2. By Product Type
8.3.4.2.3. By End User
8.3.5. Spain Veterinary Artificial Insemination Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Animal Type
8.3.5.2.2. By Product Type
8.3.5.2.3. By End User
9. ASIA-PACIFIC VETERINARY ARTIFICIAL INSEMINATION MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Animal Type
9.2.2. By Product Type
9.2.3. By End User
9.2.4. By Country
9.3. Asia-Pacific: Country Analysis
9.3.1. China Veterinary Artificial Insemination Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Animal Type
9.3.1.2.2. By Product Type
9.3.1.2.3. By End User
9.3.2. India Veterinary Artificial Insemination Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Animal Type
9.3.2.2.2. By Product Type
9.3.2.2.3. By End User
9.3.3. South Korea Veterinary Artificial Insemination Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Animal Type
9.3.3.2.2. By Product Type
9.3.3.2.3. By End User
9.3.4. Japan Veterinary Artificial Insemination Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Animal Type
9.3.4.2.2. By Product Type
9.3.4.2.3. By End User
9.3.5. Australia Veterinary Artificial Insemination Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Animal Type
9.3.5.2.2. By Product Type
9.3.5.2.3. By End User
10. SOUTH AMERICA VETERINARY ARTIFICIAL INSEMINATION MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Animal Type
10.2.2. By Product Type
10.2.3. By End User
10.2.4. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Veterinary Artificial Insemination Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Animal Type
10.3.1.2.2. By Product Type
10.3.1.2.3. By End User
10.3.2. Argentina Veterinary Artificial Insemination Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Animal Type
10.3.2.2.2. By Product Type
10.3.2.2.3. By End User
10.3.3. Colombia Veterinary Artificial Insemination Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Animal Type
10.3.3.2.2. By Product Type
10.3.3.2.3. By End User
11. MIDDLE EAST AND AFRICA VETERINARY ARTIFICIAL INSEMINATION MARKET OUTLOOK
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Animal Type
11.2.2. By Product Type
11.2.3. By End User
11.2.4. By Country
11.3. MEA: Country Analysis
11.3.1. South Africa Veterinary Artificial Insemination Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Animal Type
11.3.1.2.2. By Product Type
11.3.1.2.3. By End User
11.3.2. Saudi Arabia Veterinary Artificial Insemination Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Animal Type
11.3.2.2.2. By Product Type
11.3.2.2.3. By End User
11.3.3. UAE Veterinary Artificial Insemination Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Animal Type
11.3.3.2.2. By Product Type
11.3.3.2.3. By End User
11.3.4. Egypt Veterinary Artificial Insemination Market Outlook
11.3.4.1. Market Size & Forecast
11.3.4.1.1. By Value
11.3.4.2. Market Share & Forecast
11.3.4.2.1. By Animal Type
11.3.4.2.2. By Product Type
11.3.4.2.3. By End User
11.3.5. Turkey Veterinary Artificial Insemination Market Outlook
11.3.5.1. Market Size & Forecast
11.3.5.1.1. By Value
11.3.5.2. Market Share & Forecast
11.3.5.2.1. By Animal Type
11.3.5.2.2. By Product Type
11.3.5.2.3. By End User
12. MARKET DYNAMICS
12.1. Drivers
12.2. Challenges
13. MARKET TRENDS & DEVELOPMENTS
14. COMPETITIVE LANDSCAPE
14.1. Genus ABS
14.2. URUS Group LP
14.3. CRV
14.4. SEMEX
14.5. VikingGenetics FmbA
14.6. Select Sires Inc.
14.7. Swine Genetics International Ltd.
14.8. Stallion AI Services Ltd
14.9. ST Genetics Germany GmbH
14.10. Shipley Swine Genetics
15. STRATEGIC RECOMMENDATIONS